Evidence map›Paper›PMID 40748880›Full record

ArticlePloS one2025

Interactions of substrates and phosphinyl containing inhibitors with bacterial and human zinc proteases.

Fatema Amatur Rahman, Imin Wushur, Ida Kristine Østnes Hansen, Tor Haug, Klara Stensvåg, Bibek Chaulagain, Tra-Mi Nguyen, Olayiwola Adedotun Adekoya, Nabin Malla, Jan-Olof Winberg and 1 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fatema Amatur RahmanPharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Imin WushurPharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Ida Kristine Østnes HansenNorwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, UiT The Arctic University of Norway, Tromsø, Norway.
Tor HaugNorwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, UiT The Arctic University of Norway, Tromsø, Norway.
Klara StensvågNorwegian College of Fishery Science, Faculty of Biosciences, Fisheries and Economics, UiT The Arctic University of Norway, Tromsø, Norway.
Bibek ChaulagainPharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Tra-Mi NguyenPharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Olayiwola Adedotun AdekoyaCentre for Pharmacy, Department of Clinical Science, Faculty of Medicine, University of Bergen, Norway.
Nabin MallaPharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Jan-Olof WinbergPharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Ingebrigt SyltePharmacology and Toxicology Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.ORCID https://orcid.org/0000-0002-3290-3736

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibitors of bacterial virulence is suggested to be a promising strategy in the fight against bacterial resistance. The zinc metalloproteases (MPs) thermolysin (TLN), pseudolysin (PLN, LasB) and aureolysin (ALN) are bacterial virulence factors from the M4 family of proteases structurally resembling human zinc MPs. Knowledge about the binding modes of substrates and inhibitors with the bacterial and human zinc MPs is therefore fundamental for developing inhibitors without strong off-target effects. In the present paper, we studied the molecular interactions and cleavage of TLN, the prototype enzyme of the M4 family, with the substrate Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp)-OH (ES005) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and molecular dynamics (MD) simulations. Enzyme inhibition kinetic studies were used to test 5 compounds (H-1 - H-5) containing phosphinyl as the zinc binding group for their inhibition of TLN, PLN and ALN and of the human matrix metalloproteases MMP-9 and MMP-14. The MALDI-TOF MS results revealed that TLN cleaves ES005 at three sites. The most abundant cleavages were between Ala and Phe, and between Gly and Phe, while the third was between Ser and Ala. MD simulations with Ala or Gly in the S1 subpocket and Phe in S1' subpocket gave stable interactions between ES005 and TLN. The MD simulations with Ser in the S1 subpocket and Ala in the S1' subpocket showed larger movements of the substrate relative to the catalytic site than the others, which may explain that the Ser-Ala cleavage product was less abundant than the cleavage products from Ala-Phe and Gly-Phe. H-1 inhibited MMP-14 and MMP-9 with inhibition constants ranging from 0.89 to 30 μM but did not inhibit the bacterial zinc MPs. Induced fit docking showed that the aromatic group of H-1, that entered the S1' subpocket of the human MMPs, is too big for the S1' subpocket of the bacterial zinc MPs. H-2 inhibited the human MMPs with inhibition constants ranging from 0.53 μM (MMP-9) to 3.0 μM (MMP-14) and the bacterial zinc MPs with inhibition constants ranging from 2.5 μM (TLN) to 80 μM (ALN). Induced fit docking indicated that H-2 interacted quite differently with the human and bacterial zinc proteases, but with primed and unprimed subpockets in both. H-3, H-4 and H-5 did not inhibit any of the zinc MPs with inhibition constants < 100 μM. The MD simulations of ES005 with TLN showed that the MALDI-TOF MS results could be explained by that a Phe in S1' subpocket generate more stable interaction with TLN than an Ala in that subpocket. The docking studies indicated that the size of the S1' subpocket is an important determinant for inhibitor selectivity between bacterial and human zinc MPs.

Indexed as

Bacterial ProteinsBacterial ToxinsMetalloendopeptidasesProtease InhibitorsVirulence FactorsDrug Resistance, BacterialMolecular Dynamics SimulationPhosphinic AcidsProtein BindingRecombinant ProteinsSubstrate SpecificityThermolysinZincaureolysinBacterial ProteinsBacterial ToxinsMetalloendopeptidasesPhosphinic AcidsProtease Inhibitorspseudolysin, Pseudomonas aeruginosaRecombinant ProteinsThermolysinVirulence FactorsZinc

Identifiers

PMID40748880
PMCPMC12316308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.